AllianceBernstein
BCAB icon

AllianceBernstein’s BioAtla BCAB Stock Holding History

AllianceBernstein’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-282
Closed -$71K – 3273
2022
Q1 		$71K Hold
282
– – ﹤0.01% 3145
2021
Q4 		$277K Buy
282
+34
+14% +$43.5K ﹤0.01% 2970
2021
Q3 		$365K Sell
248
-38
-13% -$74K ﹤0.01% 2885
2021
Q2 		$606K Buy
286
+198
+225% +$447K ﹤0.01% 2737
2021
Q1 		$224K Buy
+88
New +$226K ﹤0.01% 3022

Other funds holding BCAB

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein's BCAB Position: Q2 2022 in Review

AllianceBernstein sold out of BioAtla (BCAB) in Q2 2022, closing a stake of 282 shares — an estimated $71K sold.

AllianceBernstein first reported a position in BCAB in Q1 2021 and held it in 5 quarters. The position peaked at $606K in Q2 2021. 76 funds tracked by Wall St. Rank hold BCAB as of Q2 2022.

  • AllianceBernstein reported no remaining BioAtla position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 282 BioAtla shares in Q2 2022, an estimated $71K.
  • AllianceBernstein first reported a position in BioAtla in Q1 2021 and held it in 5 quarters.
  • AllianceBernstein's BioAtla position peaked at $606K in Q2 2021.
  • 76 funds tracked by Wall St. Rank held BioAtla as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.